Dr Reddy’s Laboratories Ltd has set up a new formulation development laboratory at its facility in Miyapur here.
This was part of expansion of its existing custom service facilities. With this expansion, the laboratories will form a centre of excellence for fully integrated Active Pharmaceutical Ingredients (APIs) and formulation development services, including pre-formulation studies, prototype formulation development and process development.
“This new centre of excellence for formulation development services reflects our ongoing focus to better serve our pharma customers. Access to our integrated expertise and resources will bring their drug products to market in a more cost-efficient manner than before,” Anurag Roy, Vice-President, Global Business Head, Dr. Reddy’s Custom Pharmaceutical Services division, said in a release issued here on Tuesday.
The company’s scrip lost marginally on the Bombay Stock Exchange on Tuesday to end at Rs. 3,434.10.
